The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next ...

The US Food and Drug Administration approved a new indication for Eli Lilly’s formulation of tirzepatide to treat moderate to ...

Novo Nordisk ADR (NYSE: NVO) currently trades at $89 per share, nearly 40% below its peak level of over $145 seen in June of ...

Lilly Riggi paced Trinity Hall with 15 points in its 48-32 win over Middletown North in Tinton Falls. Riggi did an excellent ...

McDaniel College begins a $3.6 million renovation to install a learning commons in the Hoover Library in Westminster ...

From the euphoric vibes at ULTRA to the snow-covered stages of Rise Music Festival, the coastal grooves at Defected Croatia, ...

The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...

The nod, just months after topline results from SURMOUNT-OSA came out, makes it the first drug approved for this indication.

The obesity drug race is heating up in more ways than one.Eli Lilly, the world’s biggest pharmaceutical company by market ...

Stocks shook off a choppy start to finish higher Monday, as Wall Street kicked off a holiday-shortened week. The S&P 500 ...

Tirzepatide, the active ingredient in both Mounjaro for type 2 diabetes and Zepbound for weight loss, was in short supply for ...

If you have sleep apnea and obesity, tirzepatide Zepbound may offer relief and support weight loss. Ask your doctor if it’s a ...